Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07682610 · ClinicalTrials.gov registry record · NA
Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Health Services Research Intervention
A NA study, sponsored by Timothy Mullett.
- Recruiting
- Registry status
- NA
- Development phase
- 35,500
- Enrollment target
NCT07682610 is a NA study that is actively recruiting participants, run by Timothy Mullett. The registered enrollment target is 35,500 participants.
The verdict
NCT07682610, a NA study, is actively recruiting participants, sponsored by Timothy Mullett.
- RECRUITING
- Registry status
- NA
- Development phase
- 35,500 participants
- Enrollment target
Study Summary
This clinical trial studies statewide optimization of lung cancer screening (LCS) in Kentucky using the Quality Implementation of Lung Screening (QUILS™) System. Data from the Kentucky Cancer Registry shows that LCS implementation has contributed to a rapid decline in late-stage lung cancer diagnosis at twice the national average. Further, the declines are more than three times the national average decline in Kentucky's Central Appalachian region. Kentucky-based multilevel initiatives are needed to expand and accelerate this leading role and extend the LCS opportunity to more Kentuckians who are at increased risk of lung cancer. This trial may be able to accelerate optimal high-quality implementation of LCS utilizing the QUILS™ System and reduce the burden of lung cancer by assisting lung cancer screening programs located throughout Kentucky in implementing best practices in lung cancer screening by integrating the QUILS™ System domains and elements into their screening programs.
Interventions
- BEHAVIORAL Quality Implementation of Lung Cancer Screening (QUILS) System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35,500 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2028-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07682610
The ClinicalTrials.gov registry entry for NCT07682610 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 35,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Timothy Mullett, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quality Implementation of Lung Cancer Screening (QUILS) System is the first listed.
NCT07682610 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07682610 about?
NCT07682610 is a clinical study titled "Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Health Services Research Intervention". This clinical trial studies statewide optimization of lung cancer screening (LCS) in Kentucky using the Quality Implementation of Lung Screening (QUILS™) System. Data from the Kentucky Cancer Registry shows that LCS implementation has contributed to a rapid decline in late-stage lung cancer diagnosi...
What is the current status of trial NCT07682610?
This trial is currently recruiting. It is a NA study. The enrollment target is 35,500 participants. The study started on 2025-04-01. Estimated completion is 2028-06-01.
What interventions are being tested in trial NCT07682610?
The interventions under investigation include: Quality Implementation of Lung Cancer Screening (QUILS) System (BEHAVIORAL).
Who is sponsoring clinical trial NCT07682610?
This trial is sponsored by Timothy Mullett, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.